VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 115 filers reported holding VBI VACCINES INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | +4.0% | 85,783 | +35.8% | 0.00% | – |
| Q4 2022 | $25 | -100.0% | 63,176 | -37.0% | 0.00% | -100.0% |
| Q3 2022 | $71,000 | +14.5% | 100,345 | +30.1% | 0.00% | 0.0% |
| Q2 2022 | $62,000 | -7.5% | 77,111 | +91.9% | 0.00% | – |
| Q1 2022 | $67,000 | -19.3% | 40,188 | +13.9% | 0.00% | – |
| Q4 2021 | $83,000 | -65.0% | 35,295 | -53.6% | 0.00% | -100.0% |
| Q3 2021 | $237,000 | +464.3% | 76,095 | +509.9% | 0.00% | – |
| Q2 2021 | $42,000 | -57.6% | 12,477 | -60.7% | 0.00% | -100.0% |
| Q1 2021 | $99,000 | +54.7% | 31,731 | +37.4% | 0.00% | – |
| Q4 2020 | $64,000 | -90.2% | 23,092 | -89.9% | 0.00% | -100.0% |
| Q3 2020 | $655,000 | +125.1% | 229,080 | +144.4% | 0.00% | +100.0% |
| Q2 2020 | $291,000 | +459.6% | 93,713 | +70.1% | 0.00% | – |
| Q1 2020 | $52,000 | +173.7% | 55,099 | +296.1% | 0.00% | – |
| Q4 2019 | $19,000 | +18.8% | 13,910 | -58.3% | 0.00% | – |
| Q3 2019 | $16,000 | – | 33,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |